AIDS-DEMENTIA DUE TO GP120 HOMOLOGY TO NEUROLEUKIN
AIDS-DEMENTIA DUE TO GP120 HOMOLOGY TO NEUROLEUKIN
批准号:
3410308
负责人:
Mark E Gurney
金额:
$13.84万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-07-01 至 1991-06-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Neuroleukin is a polypeptide factor which exhibits both
neurotrophic and lymphokine activities. A region of the GP120
external envelope protein of HIV is partially homologous to
neuroleukin. The homology is to a segment of the ENV gene
which is conserved in all HIV isolates for which sequence
information has been reported. Recombinant neuroleukin supports
the continued survival in culture of spinal and sensory neurons.
Message encoding neuroleukin is expressed in brain and we
hypothesize that neuroleukin is important for the growth and
function of neurons within the CNS. Neuroleukin is also a
lymphokine. It is a lectin-stimulated T-cell product and acts to
induce immunoglobulin synthesis by cultured human peripheral
blood mononuclear cells. We hypothesize that the sequence
homology of GP120 to neuroleukin contributes to the subacute
encephalitis and to the polyclonal B-cell activation seen in AIDs.
Our initial experiments indicate that the GP120 protein has
neuroleukin-agonist/antagonist activity and that the activity
resides in the neuroleukin-homology segment. To extend our
work, we propose to determine if fragments of GP120 which
contain the neuroleukin homology segment are encephalitic in
animals. We also will show that the pathological effects of
GP120 fragments are due to a neuroleukin-dependent mechanism,
and that that mechanism involves agonist/antagonist interaction
with the neuroleukin receptor on neurons. The project could lead
to development of a therapeutic agent and/or a peptide vaccine
against HIV.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
HIV type 1 infection of CD4+ T cells depends critically on basic amino acid residues in the V3 domain of envelope glycoprotein 120.
HIV 1 型 CD4 T 细胞的感染关键取决于包膜糖蛋白 120 V3 结构域中的碱性氨基酸残基。
DOI:
10.1089/aid.1994.10.803
发表时间:
1994
期刊:
AIDS research and human retroviruses
影响因子:
1.5
作者:
[Okada,T, Patterson,BK, Otto,PA, Gurney,ME]
通讯作者:
Gurney,ME
Inhibition of anti-V3 domain antibody binding to human immunodeficiency virus type-1-infected cells by sulfated polysaccharides.
硫酸化多糖抑制抗 V3 结构域抗体与人类免疫缺陷病毒 1 型感染细胞的结合。
DOI:
10.1006/bbrc.1995.1577
发表时间:
1995
期刊:
Biochemical and biophysical research communications
影响因子:
3.1
作者:
[Okada,T, Patterson,BK, Gurney,ME]
通讯作者:
Gurney,ME
Restricted heterogeneity of antibody to gp120 and p24 in AIDS.
艾滋病中 gp120 和 p24 抗体的受限异质性。
DOI:
--
发表时间:
1988
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Grimaldi,LM, Roos,RP, Devare,SG, Robey,WG, Casey,JM, Gurney,ME, Apatoff,BR, Lazzarin,D]
通讯作者:
Lazzarin,D
Single basic amino acid substitutions at position 302 or 320 in the V3 domain of HIV type 1 are not sufficient to alter the antiviral activity of dextran sulfate and heparin.
1 型 HIV V3 结构域中第 302 或 320 位的单个碱性氨基酸取代不足以改变硫酸葡聚糖和肝素的抗病毒活性。
DOI:
10.1089/aid.1995.11.571
发表时间:
1995
期刊:
AIDS research and human retroviruses.
影响因子:
--
作者:
[Okada,T, Gurney,ME]
通讯作者:
Gurney,ME
PDE4B Inhibitors for Treating Brain Injury
-
批准号:8978647
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2015
-
负责人:Mark E Gurney
-
依托单位:
BPN14770 Phase 1 Single Ascending Dose Clinical Trial in Healthy Subjects
-
批准号:9077367
-
项目类别:
-
资助金额:$69.47万
-
财政年份:2015
-
负责人:Mark E Gurney
-
依托单位:
PDE4D PET Ligand for Psychiatric Disease
-
批准号:8904221
-
项目类别:
-
资助金额:$34.62万
-
财政年份:2015
-
负责人:Mark E Gurney
-
依托单位:
PDE4D Allosteric Modulators for Treating Cognitive Impairment
-
批准号:8620810
-
项目类别:
-
资助金额:$5.37万
-
财政年份:2013
-
负责人:Mark E Gurney
-
依托单位:
PDE4D Allosteric Modulators for Treating Cognitive Impairment
-
批准号:8485701
-
项目类别:
-
资助金额:$23.54万
-
财政年份:2012
-
负责人:Mark E Gurney
-
依托单位:
PDE4D-NAMs for Treating Cognitive Impairment
-
批准号:8910545
-
项目类别:
-
资助金额:$9.69万
-
财政年份:2012
-
负责人:Mark E Gurney
-
依托单位:
PDE4D Allosteric Modulators for Treating Cognitive Impairment
-
批准号:8660748
-
项目类别:
-
资助金额:$14.06万
-
财政年份:2012
-
负责人:Mark E Gurney
-
依托单位:
PDE4D Allosteric Modulators for Treating Cognitive Impairment
-
批准号:8675970
-
项目类别:
-
资助金额:$23.54万
-
财政年份:2012
-
负责人:Mark E Gurney
-
依托单位:
PDE4D Allosteric Modulators for Treating Cognitive Impairment
-
批准号:8278774
-
项目类别:
-
资助金额:$23.54万
-
财政年份:2012
-
负责人:Mark E Gurney
-
依托单位:
PDE4D Allosteric Modulators for Treating Cognitive Impairment
-
批准号:9068253
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Mark E Gurney
-
依托单位:
PDE4B Inhibitors For Treating Major Depression
-
批准号:8705018
-
项目类别:
-
资助金额:$99.0万
-
财政年份:2011
-
负责人:Mark E Gurney
-
依托单位:
PDE4B Inhibitors For Treating Major Depression
-
批准号:8590630
-
项目类别:
-
资助金额:$100.76万
-
财政年份:2011
-
负责人:Mark E Gurney
-
依托单位:
Phosphodiesterase 4 Subtype Selective Modulators for Psychiatric Disease
-
批准号:8266323
-
项目类别:
-
资助金额:$34.57万
-
财政年份:2011
-
负责人:Mark E Gurney
-
依托单位:
Phosphodiesterase Type IV (PDE4) Isoform Selective Allosteric Modulators For Psyc
-
批准号:7995142
-
项目类别:
-
资助金额:$35.0万
-
财政年份:2011
-
负责人:Mark E Gurney
-
依托单位:
AIDS-DEMENTIA DUE TO GP120 HOMOLOGY TO NEUROLEUKIN
-
批准号:3410306
-
项目类别:
-
资助金额:$16.24万
-
财政年份:1987
-
负责人:Mark E Gurney
-
依托单位:
AIDS-DEMENTIA DUE TO GP120 HOMOLOGY TO NEUROLEUKIN
-
批准号:3410307
-
项目类别:
-
资助金额:$14.6万
-
财政年份:1987
-
负责人:Mark E Gurney
-
依托单位:
海外基金